- Home
- BRY vs QTRX Comparison
BRY vs QTRX Comparison
Compare BRY & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRY
- QTRX
- Stock Information
- Founded
- BRY 1909
- QTRX 2007
- Country
- BRY United States
- QTRX United States
- Employees
- BRY N/A
- QTRX N/A
- Industry
- BRY Oil & Gas Production
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- BRY Energy
- QTRX Industrials
- Exchange
- BRY Nasdaq
- QTRX Nasdaq
- Market Cap
- BRY 249.1M
- QTRX 241.2M
- IPO Year
- BRY N/A
- QTRX 2017
- Fundamental
- Price
- BRY $3.77
- QTRX $5.99
- Analyst Decision
- BRY Hold
- QTRX Hold
- Analyst Count
- BRY 2
- QTRX 4
- Target Price
- BRY $4.00
- QTRX $11.75
- AVG Volume (30 Days)
- BRY 2.7M
- QTRX 485.2K
- Earning Date
- BRY 11-06-2025
- QTRX 11-11-2025
- Dividend Yield
- BRY 3.17%
- QTRX N/A
- EPS Growth
- BRY N/A
- QTRX N/A
- EPS
- BRY 0.07
- QTRX N/A
- Revenue
- BRY $701,914,000.00
- QTRX $125,784,000.00
- Revenue This Year
- BRY N/A
- QTRX N/A
- Revenue Next Year
- BRY N/A
- QTRX $37.89
- P/E Ratio
- BRY $58.02
- QTRX N/A
- Revenue Growth
- BRY N/A
- QTRX N/A
- 52 Week Low
- BRY $2.11
- QTRX $4.05
- 52 Week High
- BRY $5.90
- QTRX $15.67
- Technical
- Relative Strength Index (RSI)
- BRY 54.72
- QTRX 58.57
- Support Level
- BRY $3.60
- QTRX $5.62
- Resistance Level
- BRY $3.89
- QTRX $6.29
- Average True Range (ATR)
- BRY 0.13
- QTRX 0.28
- MACD
- BRY -0.05
- QTRX 0.05
- Stochastic Oscillator
- BRY 30.77
- QTRX 52.34
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.